Blonanserin, an antipsychotic and dopamine D₂/D₃receptor antagonist, and ameliorated alcohol dependence.

@article{Takaki2013BlonanserinAA,
  title={Blonanserin, an antipsychotic and dopamine D₂/D₃receptor antagonist, and ameliorated alcohol dependence.},
  author={Manabu Takaki and Hiroshi Ujike},
  journal={Clinical neuropharmacology},
  year={2013},
  volume={36 2},
  pages={68-9}
}
Blonanserin (BNS) is used for treatment of both positive and negative symptoms of schizophrenia in Japan and Korea. Because BNS has weak α1 receptor blocking activities and is almost devoid of histamine H1 and muscarinic M1 antagonist activity, BNS is better tolerated than other atypical antipsychotics. A high degree of D₃ receptor blockage is reported to… CONTINUE READING